This week, LFA-supported researchers will share results of a study that could help expedite the delivery of new and safer therapies to people with lupus.
New study results show that a short questionnaire designed for adolescents to assess the impact of lupus on quality of life makes it easier for them to report their mental, physical, and social well-being.
In some diseases, like lupus, sex-based differences may be the key to unlocking the mysteries and getting closer to treatments and cures.
Participating in research can be a rewarding experience, and is essential to improve the quality of life of people with lupus.
Not all patients who share a certain organ involvement can be treated with the same medicine at the same dose. In this piece, Foundation Medical Director Dr. Joan Merrill argues that improved classification of lupus can lead to better treatment.
Lupus Foundation of America supported study demonstrates that blocking STAT5 reduces the production of CD154 by half.
Additional data from the CDC National Lupus Patient Registry project demonstrates that lupus is a widespread disease with a significant impact.
Although the overall risk is small, children born to mothers with lupus may have a higher risk of autism spectrum disorders than children born to mothers without the disease, according to the results of a study presented this week at the American College of Rheumatology Annual Scientific Meeting in San Diego.